152 results
Page 5 of 8
8-K
9qa713ovzr
25 Jul 11
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
8-K
EX-4.2
rj2d 1u382zpe
20 Apr 11
Unregistered Sales of Equity Securities
12:00am
8-K
EX-4.1
pj6sps q0jz
20 Apr 11
Unregistered Sales of Equity Securities
12:00am
8-K
r90pk7
16 Mar 11
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
8-K
p0y3jfs64g4ny0da
1 Mar 11
Regulation FD Disclosure
12:00am
424B5
ekugal
13 Jan 11
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
if6d6f9b989 l6
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
8-K
9oa1q2h17 if512j5mmo
13 Jan 11
Provectus Pharmaceuticals, Inc. Announces Registered Direct Offering of Common Stock and Warrants In Aggregate Amount of $5.1 Million
12:00am
8-K
EX-10.2
zvga5wd0zsgkv77r7q72
23 Dec 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
a9yb006rng5v6372k3h
23 Dec 10
Entry into a Material Definitive Agreement
12:00am
424B5
8538vlj5sstbm8siw8
23 Dec 10
Prospectus supplement for primary offering
12:00am
POS AM
gpqjigtw8acopg
27 Jul 10
Prospectus update (post-effective amendment)
12:00am
S-3/A
u9r2zhwnhv74 2eo
12 Jul 10
Shelf registration (amended)
12:00am